Persistent cognitive impairment after cerebral malaria: models, mechanisms and adjunctive therapies

References

• Kappe SH, Vaughan AM, Boddey JA, Cowman AF. That was then but this is now: malaria research in the time of an eradication agenda. Science328(5980), 862–866 (2010).
   PubMed Web of Science ®Google Scholar
• Hay SI, Okiro EA, Gething PW et al. Estimating the global clinical burden of Plasmodium falciparum malaria in 2007. PLoS Med.7(6), e1000290 (2010).
   PubMed Web of Science ®Google Scholar
• Rosenthal PJ. Artesunate for the treatment of severe falciparum malaria. N. Engl. J. Med.358(17), 1829–1836 (2008).
   PubMed Web of Science ®Google Scholar
• de Souza JB, Hafalla JC, Riley EM, Couper KN. Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology137(5), 755–772 (2010).
   PubMed Web of Science ®Google Scholar
• Golenser J, McQuillan J, Hee L, Mitchell AJ, Hunt NH. Conventional and experimental treatment of cerebral malaria. Int. J. Parasitol.36(5), 583–593 (2006).
   PubMedGoogle Scholar
• Carter JA, Mung’ala-Odera V, Neville BG et al. Persistent neurocognitive impairments associated with severe falciparum malaria in Kenyan children. J. Neurol. Neurosurg. Psychiatry76(4), 476–481 (2005).
   PubMed Web of Science ®Google Scholar
• Carter JA, Ross AJ, Neville BG et al. Developmental impairments following severe falciparum malaria in children. Trop. Med. Int. Health10(1), 3–10 (2005).
   PubMed Web of Science ®Google Scholar
• Boivin MJ, Bangirana P, Byarugaba J et al. Cognitive impairment after cerebral malaria in children: a prospective study. Pediatrics119(2), e360–e366 (2007).
   PubMed Web of Science ®Google Scholar
• John CC, Bangirana P, Byarugaba J et al. Cerebral malaria in children is associated with long-term cognitive impairment. Pediatrics122(1), e92–e99 (2008).
   PubMed Web of Science ®Google Scholar
• Birbeck GL. Seizures in rural Zambia. Epilepsia41(3), 277–281 (2000).
   PubMedGoogle Scholar
• Murphy SC, Breman JG. Gaps in the childhood malaria burden in Africa: cerebral malaria, neurological sequelae, anemia, respiratory distress, hypoglycemia, and complications of pregnancy. Am. J. Trop. Med. Hyg.64(1–2 Suppl.), 57–67 (2001).
   PubMed Web of Science ®Google Scholar
• Taylor TE, Fu WJ, Carr RA et al. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat. Med.10(2), 143–145 (2004).
   PubMed Web of Science ®Google Scholar
• Renia L, Gruner AC, Snounou G. Cerebral malaria: in praise of epistemes. Trends Parasitol.26(6), 275–277 (2010).
   PubMedGoogle Scholar
• Charunwatthana P, Abul Faiz M, Ruangveerayut R et al.N-acetylcysteine as adjunctive treatment in severe malaria: a randomized, double-blinded placebo-controlled clinical trial. Crit. Care Med.37(2), 516–522 (2009).
   PubMedGoogle Scholar
• White NJ, Turner GD, Medana IM, Dondorp AM, Day NP. The murine cerebral malaria phenomenon. Trends Parasitol.26(1), 11–15 (2009).
   PubMedGoogle Scholar
• Quintana-Murci L, Alcais A, Abel L, Casanova JL. Immunology in natura: clinical, epidemiological and evolutionary genetics of infectious diseases. Nat. Immunol.8(11), 1165–1171 (2007).
   PubMedGoogle Scholar
• Reis PA, Comim CM, Hermani F et al. Cognitive dysfunction is sustained after rescue therapy in experimental cerebral malaria, and is reduced by additive antioxidant therapy. PLoS Pathog.6(6), e1000963 (2010).
   Google Scholar
• Desruisseaux MS, Gulinello M, Smith DN et al. Cognitive dysfunction in mice infected with Plasmodium berghei strain ANKA. J. Infect. Dis.197(11), 1621–1627 (2008).
   PubMedGoogle Scholar
• Dondorp AM, Omodeo-Sale F, Chotivanich K, Taramelli D, White NJ. Oxidative stress and rheology in severe malaria. Redox Rep.8(5), 292–294 (2003).
   PubMed Web of Science ®Google Scholar
• Carvalho LJ. Murine cerebral malaria: how far from human cerebral malaria? Trends Parasitol.26(6), 271–272 (2010).
   PubMedGoogle Scholar
• Riley EM, Couper KN, Helmby H et al. Neuropathogenesis of human and murine malaria. Trends Parasitol.26(6), 277–278 (2010).
   PubMed Web of Science ®Google Scholar
• Ritter C, Andrades ME, Reinke A, Menna-Barreto S, Moreira JC, Dal-Pizzol F. Treatment with N-acetylcysteine plus deferoxamine protects rats against oxidative stress and improves survival in sepsis. Crit. Care Med.32(2), 342–349 (2004).
   PubMed Web of Science ®Google Scholar
• Barichello T, Machado RA, Constantino L et al. Antioxidant treatment prevented late memory impairment in an animal model of sepsis. Crit. Care Med.35(9), 2186–2190 (2007).
   PubMed Web of Science ®Google Scholar
• Gordeuk V, Thuma P, Brittenham G et al. Effect of iron chelation therapy on recovery from deep coma in children with cerebral malaria. N. Engl. J. Med.327(21), 1473–1477 (1992).
   PubMed Web of Science ®Google Scholar
• Weiss G, Thuma PE, Mabeza G, Werner ER, Herold M, Gordeuk VR. Modulatory potential of iron chelation therapy on nitric oxide formation in cerebral malaria. J. Infect. Dis.175(1), 226–230 (1997).
   PubMed Web of Science ®Google Scholar
• Watt G, Jongsakul K, Ruangvirayuth R. A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. Q. J. Med.95(5), 285–290 (2002).
   Google Scholar
• Hunt NH, Grau GE, Engwerda C et al. Murine cerebral malaria: the whole story. Trends Parasitol.26(6), 272–274 (2010).
   PubMed Web of Science ®Google Scholar
• Stevenson MM, Gros P, Olivier M, Fortin A, Serghides L. Cerebral malaria: human versus mouse studies. Trends Parasitol.26(6), 274–275 (2010).
   PubMed Web of Science ®Google Scholar
• Miyazaki Y, Bunting M, Stafforini DM et al. Integrin aDb2 is dynamically expressed by inflamed macrophages and alters the natural history of lethal systemic infections. J. Immunol.180(1), 590–600 (2008).
   PubMedGoogle Scholar
• Casals-Pascual C, Idro R, Picot S, Roberts DJ, Newton CR. Can erythropoietin be used to prevent brain damage in cerebral malaria? Trends Parasitol.25(1), 30–36 (2009).
   PubMedGoogle Scholar
• Cabrales P, Zanini GM, Meays D, Frangos JA, Carvalho LJ. Murine cerebral malaria is associated with a vasospasm-like microcirculatory dysfunction, and survival upon rescue treatment is markedly increased by nimodipine. Am. J. Pathol.176(3), 1306–1315 (2010).
   PubMed Web of Science ®Google Scholar